Salinazid

CAS No. 495-84-1

Salinazid( Salizid | Nilazid | Nupasal | Salizide | Salicylaldehyde isonicotinoyl hydrazone | SIH1 | )

Catalog No. M28013 CAS No. 495-84-1

Salinazid is a potent Cu(II) ionophore which preferentially kills HepG2 cells over HUVEC cells, and is superior to clioquinol.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
10MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Salinazid
  • Note
    Research use only, not for human use.
  • Brief Description
    Salinazid is a potent Cu(II) ionophore which preferentially kills HepG2 cells over HUVEC cells, and is superior to clioquinol.
  • Description
    Salinazid is a potent Cu(II) ionophore which preferentially kills HepG2 cells over HUVEC cells, and is superior to clioquinol.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Salizid | Nilazid | Nupasal | Salizide | Salicylaldehyde isonicotinoyl hydrazone | SIH1 |
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antifungal|tuberculosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    495-84-1
  • Formula Weight
    241.25
  • Molecular Formula
    C13H11N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 250 mg/mL (1036.27 m)
  • SMILES
    O=C(N/N=C/C1=CC=CC=C1O)C2=CC=NC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Imramovsky A, et al. Investigating spectrum of biological activity of 4- and 5-chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides. Molecules. 2011 Mar 14;16(3):2414-30.
molnova catalog
related products
  • FIDAS-5

    FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.?FIDAS-5 has anticancer activities.?FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.

  • 10-Deacetylcephaloma...

    The barks of Cephalotaxus sinensis.

  • Ramucirumab

    Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.